Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ZLTQ Guru Trades in Q1 2016

Columbia Wanger 726,246 sh (New)
Jim Simons 594,400 sh (+472.36%)
Paul Tudor Jones Sold Out
Steven Cohen 1,698,300 sh (-26.79%)
RS Investment Management 781,322 sh (-33.90%)
» More
Q2 2016

ZLTQ Guru Trades in Q2 2016

Chuck Royce 81,000 sh (New)
RS Investment Management 1,056,821 sh (+35.26%)
Steven Cohen 2,219,762 sh (+30.70%)
Columbia Wanger 533,203 sh (-26.58%)
Jim Simons 45,910 sh (-92.28%)
» More
Q3 2016

ZLTQ Guru Trades in Q3 2016

Paul Tudor Jones 5,947 sh (New)
Jim Simons 161,600 sh (+251.99%)
Chuck Royce 108,000 sh (+33.33%)
Columbia Wanger 412,602 sh (-22.62%)
Steven Cohen 797,696 sh (-64.06%)
» More
Q4 2016

ZLTQ Guru Trades in Q4 2016

Joel Greenblatt 21,960 sh (New)
Paul Tudor Jones 31,742 sh (+433.75%)
Jim Simons 372,100 sh (+130.26%)
Chuck Royce 125,000 sh (+15.74%)
Columbia Wanger 248,042 sh (-39.88%)
Steven Cohen 125,506 sh (-84.27%)
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:LIVN, NYSE:PEN, OTCPK:NHNKY, NYSE:GMED, NYSE:NVRO, NAS:WMGI, NAS:CYNO, NAS:INGN, OTCPK:GGNDF, OTCPK:IOBCF, NAS:BABY, NAS:CNMD, NAS:IART, NAS:SPNC, OTCPK:EKTAY, NYSE:ITGR, NAS:VASC, NAS:CSII, OTCPK:FSPKF, NAS:MDXG » details
ZELTIQ Aesthetics Inc is a medical technology company. The Company is engaged in developing and commercializing products utilizing its proprietary controlled cooling technology platform.

ZELTIQ Aesthetics Inc was incorporated in Delaware in March 2005 as Juniper Medical, Inc. In July 2007, it changed its name to ZELTIQ Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled cooling technology platform. Its first commercial product, the CoolSculpting system, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Ratios

vs
industry
vs
history
Forward P/E 125.00
ZLTQ's Forward P/E is ranked lower than
99.99% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 23.92 vs. ZLTQ: 125.00 )
Ranked among companies with meaningful Forward P/E only.
N/A

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $327.3
EPS (TTM) $ 0.74
Beta1.20
Short Percentage of Float26.37%
52-Week Range $20.11 - 56.18
Shares Outstanding (Mil)40.21

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 351 411 481
EPS ($) -0.03 0.45 0.89
EPS w/o NRI ($) -0.03 0.45 0.89
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for ZLTQ

Headlines

Articles On GuruFocus.com
Steven Cohen's Newest Buys, Additions and Reductions Mar 04 2015 
Steven Cohen Buys New Drug Stock, Triples Investment in Medical Company Jan 25 2015 
4 Stocks To Buy, 1 To Avoid In 2012 Feb 18 2012 
Weekly CFO Sales Highlight: INFA, DHR, AN, SMTC, ZLTQ Oct 31 2011 

More From Other Websites
[$$] Gormley's Take: Body Beautification Is Sexy Business Feb 22 2017
Medtronic Earnings Rebound in Third Quarter, Shares Climb Feb 21 2017
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of... Feb 17 2017
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ Aesthetics,... Feb 16 2017
ZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Feb 15 2017
ZELTIQ INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC... Feb 15 2017
WEISSLAW LLP: ZELTIQ Aesthetics, Inc. Acquisition May Not Be in the Best Interests of ZLTQ... Feb 14 2017
ZELTIQ AESTHETICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the... Feb 14 2017
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ... Feb 14 2017
Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence in the Body Contouring Business Feb 14 2017
Botox-maker Allergan is betting that zapping your fat is worth $4 billion Feb 14 2017
ZELTIQ Aesthetics downgraded by Leerink Partners and Canaccord Genuity Feb 14 2017
Harwood Feffer LLP Announces Investigation of ZELTIQ Aesthetics, Inc. Feb 13 2017
ZELTIQ AESTHETICS INC Files SEC form 8-K, Other Events Feb 13 2017
Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13% Feb 13 2017
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion Feb 13 2017
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion Feb 13 2017
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion Feb 13 2017
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion Feb 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)